Revenue: $1,250 thousand; YoY N/A; QoQ N/A
Gross Profit: -$8,953 thousand; Gross Margin: -7.16%
Operating Income: -$1,923 thousand; Operating Margin: -1,538.52%
Net Income: -$1,559.8 thousand; Net Margin: -1,247.82%
Earnings Per Share (EPS): -$0.0003; Diluted EPS: -$0.0003
EBITDA: -$1,549.6 thousand; EBITDA Margin: -1,239.66%
Cash Flow: Net cash provided by operating activities -$1,186 thousand; Free cash flow -$1,186 thousand
Net Change in Cash: -$1,163.5 thousand; Cash at End of Period: $33,465.159 thousand
Balance Sheet Highlights: Total assets $35,735.409 thousand; Cash & cash equivalents $33,465.159 thousand; Short-term investments $1,978.096 thousand; Total current assets $35,545.313 thousand; Total current liabilities $766.842 thousand; Total stockholders’ equity $34,968.567 thousand; Retained earnings -$101,638.328 thousand; Net debt / net cash position: -$33,465.159 thousand
Key Operational Note: Weighted average shares outstanding 5,438,414,015; Revenue base and margins are highly sensitive to R&D cycles and any potential licensing or grant-based revenue opportunities.